Korean Firm Targets Cancer's Environment, Not Just Tumors

A South Korean biotech company is flipping the script on cancer treatment by attacking the fortress around tumors instead of just the cancer cells themselves.

Their drug could help overcome one of chemotherapy's biggest problems: resistance.